Eurogentec
It is a major step in the growth strategy of Eurogentec and bio-production in Belgium. I thank Wallonia for its major support in the implementation of this project
Lieven Janssens
Executive Vice President of Kaneka Eurogentec

Kaneka Eurogentec expands its production capacity in Wallonia

In June 2017, Kaneka Eurogentec, active in development of custom bio-production (CDMO) at the service of pharmaceutical companies, announced the future construction of a new production zone next to the existing facility.

This expansion will enable production on a larger scale of biopharmaceutical products used in final phase clinical trials and will reinforce its current bio-production capacities of molecules designed for initial phase clinical studies.

The company, created as a spin-off of ULg and now an integral part of the Kaneka group, employs 336 people, 260 of which in Liege: 23 of them have been hired in the past two years. It is recognised as one of the largest suppliers for genomic and proteomic research and enjoyed 8.5% growth in 2016-2017. Lieven Janssens, Executive Vice President of Kaneka Eurogentec, declared: "It is a major step in the growth strategy of Eurogentec and bio-production in Belgium. I thank Wallonia for its major support in the implementation of this project".

misc.back to top back to top

Subscribe to thenewsletter

Customize your browsing experience
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida.
Choisissez parmi les options ci-dessous.

Choisissez une option

Formulaire de contact Contactez-nous sur votre projet Contactez-nous via Messenger